Apoptosis induced by a new flavonoid in human hepatoma HepG2 cells involves reactive oxygen species-mediated mitochondrial dysfunction and MAPK activation

被引:44
作者
Liu, Huibin [1 ]
Xiao, Yuling [2 ]
Xiong, Chaomei [1 ]
Wei, Anhua [1 ]
Ruan, Jinlan [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Key Lab Nat Med Chem & Resources Evaluat Hubei Pr, 13 Hangkong Rd, Wuhan 430030, Peoples R China
[2] Wuhan Univ, Coll Pharm, State Key Lab Virol, Wuhan 430072, Peoples R China
关键词
Flavonoid; HepG2; cell; Reactive oxygen species; JNK; p38; Apoptosis; STRESS-RESPONSE; CANCER-CELLS; C-JUN; BCL-2; INDUCTION; DEATH; PROTOAPIGENONE; INHIBITION; MODULATION; KINASE;
D O I
10.1016/j.ejphar.2010.12.036
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Earlier reports suggest that protoapigenone showed remarkable anticancer activities. In the present study, the cytotoxic effect of a new flavonoid, 2-(cis-1, 2-dihydroxy 4-oxo-cyclohex-5-enyl)-5, 7-dihydroxy-chromone (DEDC), which is a protoapigenone analog, was investigated in human hepatoma HepG2 cells. We found that hepatoma cells were highly susceptible to DEDC in contrast with normal cells. The sustainable and rapid generation of reactive oxygen species was observed in DEDC-induced cell death. Following oxidative stress, DEDC sequentially decreased mitochondrial membrane potential (Delta psi m), reduced Bcl-2 expression, increased cytochrome c release, and activated caspase-3, -8, and -9. Phosphorylation of c-Jun N-terminal kinase (INK) and p38 mitogen activated protein kinase (MAPK) was stimulated by treatment with DEDC. To further investigate the mechanisms of the DEDC-induced cell death, we examined the effects of reactive oxygen species scavenger N-acetyl-L-cysteine (NAC) and selective inhibitors for MAPK pathways on the cell death. The DEDC-induced cell death was significantly inhibited by both NAC and JNK inhibitor SP600125, but promoted by p38 MAPK inhibitor, SB203580. Together, DEDC may have antitumor effects in HepG2 cells through reactive oxygen species production as well as activation of MAPK signaling pathways. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:209 / 216
页数:8
相关论文
共 31 条
  • [1] The Bcl-2 protein family: Arbiters of cell survival
    Adams, JM
    Cory, S
    [J]. SCIENCE, 1998, 281 (5381) : 1322 - 1326
  • [2] Induction of oxidative stress and TNF-α secretion by dichloroacetonitrile, a water disinfectant by-product, as possible mediators of apoptosis or necrosis in a murine macrophage cell line (RAW)
    Ahmed, AE
    Aronson, J
    Jacob, S
    [J]. TOXICOLOGY IN VITRO, 2000, 14 (03) : 199 - 210
  • [3] [Anonymous], 1993, FREE RADICALS BASIC
  • [4] The Bcl-2 protein family
    Antonsson, B
    Martinou, JC
    [J]. EXPERIMENTAL CELL RESEARCH, 2000, 256 (01) : 50 - 57
  • [5] Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo
    Chang, Hsueh-Ling
    Su, Jinu-Huang
    Yeh, Yao-Tsung
    Lee, Yi-Chen
    Chen, Huey-May
    Wu, Yang-Chang
    Yuan, Shyng-Shiou F.
    [J]. CANCER LETTERS, 2008, 267 (01) : 85 - 95
  • [6] Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2
    Chang, Hsueh-Ling
    Wu, Yang-Chang
    Su, Jinu-Huang
    Yeh, Yao-Tsung
    Yuan, Shyng-Shiou F.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 325 (03) : 841 - 849
  • [7] The Bcl-2 family: roles in cell survival and oncogenesis
    Cory, S
    Huang, DCS
    Adams, JM
    [J]. ONCOGENE, 2003, 22 (53) : 8590 - 8607
  • [8] Modulation of MDM2/p53 and cyclin-activating kinase during the megakaryocyte differentiation of human erythroleukemia cells
    Datta, NS
    Long, MW
    [J]. EXPERIMENTAL HEMATOLOGY, 2002, 30 (02) : 158 - 165
  • [9] Mitochondrial membrane permeabilisation by Bax/Bak
    Esposti, MD
    Dive, C
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 304 (03) : 455 - 461
  • [10] Tumor-targeted induction of oxystress for cancer therapy
    Fang, J.
    Nakamura, H.
    Iyer, A. K.
    [J]. JOURNAL OF DRUG TARGETING, 2007, 15 (7-8) : 475 - 486